Reflux monitoring: On or off therapy

American Journal of Gastroenterology

Volumn 106, Issue 2, 2011, Pages 183-185

  Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; BIOLOGICAL MONITORING; CLINICAL FEATURE; ENDOSCOPIC THERAPY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; STOMACH FUNDOPLICATION;

ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMP INHIBITORS;

EID: 79751513947     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.318     Document Type: Article

References (14)

1. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1392-413.e5.
2. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007;102:668-85. (Pubitemid 46328165)
3. Numans ME, Lau J, de Wit NJ et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-27.
4. Wiener GJ, Richter JE, Copper JB et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
5. Weusten BL, Roelofs JM, Akkermans LM et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741-5. (Pubitemid 24357628)
6. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
7. Shay S. Esophageal impedance monitoring: the ups and downs of a new test. Am J Gastroenterol 2004;99:1020-2. (Pubitemid 38917802)
8. Vela MF, Camacho-Lobato L, Srinivasan R et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-606. (Pubitemid 32523479)
9. Mainie I, Tutuian R, Shay S et al. Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedancepH monitoring. Gut 2006;55:1398-402. (Pubitemid 44476780)
10. Sifrim D, Holloway R, Silny J et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001;120:1588-98. (Pubitemid 32523478)
11. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005;100:283-9. (Pubitemid 40314510)
12. Pritchett JM, Aslam M, Slaughter JC et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009;7:743-8.
13. Hemmink GJ, Bredenoord AJ, Weusten BL et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am J Gastroenterol 2008;103:2446-53.
14. Slaughter JC, Goutte M, Vaezi MF. Neither SI or SAP are reliable tools for assessing symptoms and reflux events [abstr]. Gastroenterology 2010;138(Suppl 1):S487.